АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ КАК ФАКТОР РИСКА ПОВЫШЕННОЙ ЛЕТАЛЬНОСТИ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ МЕТОДОМ ХРОНИЧЕСКОГО ГЕМОДИАЛИЗА, И ПОДХОДЫ К ЕЕ КОРРЕКЦИИ
https://doi.org/10.24884/1561-6274-2003-7-3-7-13
Аннотация
Артериальная гипертензия как фактор риска повышенной летальности у больных, получающих лечение методом хронического гемодиализа, и подходы к ее коррекции.
Об авторах
А. В. Смирнов
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
В. Г. Рыков
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
Е. Д. Суглобова
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
А. Н. Васильев
Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова
Россия
Россия
Список литературы
1. Levey SA Eknoyan G. Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 1999; 14: 828-833
2. US Renal Data System. Patients mortality and survival. Am J Kidney Dis 1995; 26 [Suppl 2] 69-84
3. Foley RN, Parfrey PS, Harnett JD. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney lnt 1995; 47: 186-192
4. Zucchelli P. The careful correction of renal insufficiency abnormalities: early is good. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 2-6
5. Foley RN, Parfrey PS. Epidemiology of cardiovascular disease in chronic renal disease. Am Soc Nephrol 1998; 9: 16-23
6. Cohen ER Hypertension in chronic hemodialysis: viewing a paradox, and some notes on therapy. Dial & Transplant 2000; 29:535-542
7. Mazzuchi N, Carbonell E, Fernandez-Cean J. Importance of blood pressure control in hemodialysis patient survival. Kidney Int 2000; 58: 2147-2154
8. Rahman M, Sehgal AR, Smith MC. Interdialytic weight gain, compliance with dialysis regimen, and age are independent predictors of blood pressure in hemodialysis patients. Am J Kidney Dis 2000; 35: 257-265
9. Rocco MV, Yan G, Heyka RJ, Benz R, Cheung AK. Risk factors for hypertension in chronic haemodialysis patients: baseline data from the HEMO study. Am J Nephrol 2001; 21: 280-288
10. Evert J Dorhout Mees. Hypertension in haemodialysis patients: who cares? Nephrol Dial Transplant 1999; 14: 28-30
11. Dhakal MP, Sloand JA. Prevalence of hypertension and adequacy of blood pressure control in hemodialysis patients. Dial & Transplant 2000; 29: 628-637
12. Scribner BH. Can antihypertensive medications control BP in haemodialysis patients: yes or no. Nephrol Dial Transplant 1999; 14:2599-2601
13. Salem M. Hypertension in haemodialysis population: any relationship to 2-years survival? Nephrol Dial Transplant 1999; 14: 125-128
14. Tozawa M et al. Hypertension in dialysis patients: a cross-sectional analysis. Nippon Jinzo Gakkai Shi 1996; 38: 129-135
15. Port FK, Hulbert-Shearon TE, Wolfe RA et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 1999; 33: 507-517
16. Zager PG, Nikolic J et al. «U» curve association of blood pressure and mortality in haemodialysis patients. Kidney Int 1998;54:561-569
17. Foley RN, Herzog CA, Collins AJ. Blood pressure and long-term mortality in United States haemodialysis patients: USRDSWaves 3 and 4 Study. Kidneylnt 2002; 62: 1784-1790
18. Lowrie EG. Acute-phase inflammatory process contributed to malnutrition, anemia, and possibly other abnormalities in dialysis patients. Am J Kidney Dis 1998; 32 [Suppl 4]: 105-110
19. Shinzato T, Naki S, Akiba T et al. Survival in long-term haemodialysis patients: results from the annual survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12:889-898
20. Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. J Am Med Assoc 2002; 287: 1548-1555
21. Zoccali C. Arterial pressure components and cardiovascular risk in end-stage renal disease. Nephrol Dial Transplant 2003; 18: 249-252
22. Sytkowski PA, Kannel WB, D’Agnostino RB. Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. New Eng J Med 1990; 322: 1635-1641
23. Charra B, Laurent G, Calemard E, Terrat JC et al. Survival in dialysis and blood pressure control. Contrib Nephrol 1994; 106: 179-185
24. Fisch BJ, Spiegel D. Assessment of excess fluid distribution in chronic haemodialysis patients using bioimpedance spectroscopy. Kidney Int 1996; 49: 1105-1109
25. Tomson C. Advising dialysis patients to restrict fluid intake without restricting sodium intake is not based on evidence and is a waste of time. Nephrol Dial Transplant 2001; 16:1538-1542
26. Krautzig S. Dietary salt restriction and reduction of dialysate sodium to controle hypertension in maintenance haemodialysis patients. Nephrol Dial Transplant 1998; 13: 552-553
27. Donohoe P1Farmer C, Dallyn P et al. Low-sodium hemodialysis without fluid removal improves blood pressure control in chronic dialysis patients. Kidney Int 1997; 52: 1110
28. Hamlyn JM, Hamilton BP, Manunta P. Endogenous oubain sodium balance and blood pressure: a review and hypothesis. J Hypertens 1996; 14: 151-167
29. Converse JR1 Jacobsen TN, Toto RD et al. Simpathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327: 1912-1918
30. Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 2001; 16: 1538-1542
31. Charra B, Calemard E, Laurent G. Importance of treatment time and blood pressure control in achieving longterm survival on dialysis. Am J Nephrol 1996; 16: 35-44
32. Luik AJ, Charra B1 Katzarski K et al. Blood pressure control and hemodynamic changes in patients on long treatment time dialysis. J Am Soc Nephrol 1994; 5: 521-522
33. Luik AJ, Sande FM, Weideman P et al. The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in haemodialysis patients: a prospective study. Am J Nephrol 2001; 21: 471-478
34. Katzarski K, Charra B, Laurent G et al. Fluid state and blood pressure control in patients treated with long and short haemodialysis. Nephrol Dial Transplant 1999; 14: 369-375
35. Sherman RA, Daniel A, Cody RP.The effect of interdiaIytic weight gain on predialysis blood pressure. Artif Organs 1993; 17:770-774
36. Savage T, Fabbian F, Giles M, Tomson CR, Raine AE. Interdialytic weight gain and 48-h blood pressure in haemodialysis patients. Nephrol Dial Transplant 1997; 12: 2308-2311
37. Vaziri ND. Mechanism of erythropoietin-induced hypertension. Am J Kidney Dis 1999; 33: 821-828
38. Neff M, Kim K, Persoff M. Hemodynamics of uremic anemia. Circulation 1972; 46: 456-464
39. Eschbach EJ, Abdulhadi MH, Browne JK et al. Recombinant human of erythropoietin in anemic patients with end-stage renal disease: results of phase III multicenter clinical trial. Ann Intern Med 1989; 111: 992-1000
Рецензия
Для цитирования:
Смирнов А.В., Рыков В.Г., Суглобова Е.Д., Васильев А.Н. АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ КАК ФАКТОР РИСКА ПОВЫШЕННОЙ ЛЕТАЛЬНОСТИ У БОЛЬНЫХ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ МЕТОДОМ ХРОНИЧЕСКОГО ГЕМОДИАЛИЗА, И ПОДХОДЫ К ЕЕ КОРРЕКЦИИ. Нефрология. 2003;7(3):7-13. https://doi.org/10.24884/1561-6274-2003-7-3-7-13
For citation:
Smirnov A.V., Rykov V.G., Suglobova E.D., Vasiliev A.N. ARTERIAL HYPERTENSION AS A RISK FACTOR OF HIGHER MORTALITY IN CHRONIC HEMODIALYSIS PATIENTS AND APPROACHES TO ITS CORRECTION. Nephrology (Saint-Petersburg). 2003;7(3):7-13. (In Russ.) https://doi.org/10.24884/1561-6274-2003-7-3-7-13
Просмотров:
310
Послать статью по эл. почте 